COCHLEAR LTD ADR 1/2/O.N. (F:OC50) — Market Cap & Net Worth
Market Cap & Net Worth: COCHLEAR LTD ADR 1/2/O.N. (OC50)
COCHLEAR LTD ADR 1/2/O.N. (F:OC50) has a market capitalization of $4.65 Billion (€3.98 Billion) as of August 16, 2026. Listed on the F stock exchange, this Germany-based company holds position #3763 globally and #679 in its home market, demonstrating a -42.10% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying COCHLEAR LTD ADR 1/2/O.N.'s stock price €30.40 by its total outstanding shares 130797362 (130.80 Million). See net asset quality index of COCHLEAR LTD ADR 1/2/O.N. to understand what proportion of total assets are financed by equity.
COCHLEAR LTD ADR 1/2/O.N. Market Cap History: 2021 to 2026
COCHLEAR LTD ADR 1/2/O.N.'s market capitalization history from 2021 to 2026. Data shows change from $9.97 Billion to $6.18 Billion (-12.24% CAGR). Also see COCHLEAR LTD ADR 1/2/O.N. (OC50) total assets for a full breakdown of the balance sheet.
COCHLEAR LTD ADR 1/2/O.N. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how COCHLEAR LTD ADR 1/2/O.N.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check COCHLEAR LTD ADR 1/2/O.N. stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
4.83x
COCHLEAR LTD ADR 1/2/O.N.'s market cap is 4.83 times its annual revenue
Latest Price to Earnings (P/E) Ratio
29.10x
COCHLEAR LTD ADR 1/2/O.N.'s market cap is 29.10 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $9.43 Billion | $1.65 Billion | $289.10 Million | 5.72x | 32.62x |
| 2023 | $13.86 Billion | $1.94 Billion | $300.60 Million | 7.16x | 46.11x |
| 2024 | $13.23 Billion | $2.24 Billion | $356.80 Million | 5.92x | 37.07x |
| 2025 | $11.32 Billion | $2.34 Billion | $388.90 Million | 4.83x | 29.10x |
Competitor Companies of OC50 by Market Capitalization
Companies near COCHLEAR LTD ADR 1/2/O.N. in the global market cap rankings as of August 16, 2026.
Key companies related to COCHLEAR LTD ADR 1/2/O.N. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #107 globally with a market cap of $193.45 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #183 globally with a market cap of $129.81 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #240 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #107 | Abbott Laboratories | NYSE:ABT | $193.45 Billion | $111.25 |
| #183 | Stryker Corporation | NYSE:SYK | $129.81 Billion | $339.21 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #240 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $91.27 |
COCHLEAR LTD ADR 1/2/O.N. Historical Marketcap From 2021 to 2026
Between 2021 and today, COCHLEAR LTD ADR 1/2/O.N.'s market cap moved from $9.97 Billion to $ 6.18 Billion, with a yearly change of -12.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €6.18 Billion | -45.41% |
| 2025 | €11.32 Billion | -14.45% |
| 2024 | €13.23 Billion | -4.58% |
| 2023 | €13.86 Billion | +46.97% |
| 2022 | €9.43 Billion | -5.35% |
| 2021 | €9.97 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of COCHLEAR LTD ADR 1/2/O.N. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.65 Billion USD |
| MoneyControl | $4.65 Billion USD |
| MarketWatch | $4.65 Billion USD |
| marketcap.company | $4.65 Billion USD |
| Reuters | $4.65 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About COCHLEAR LTD ADR 1/2/O.N.
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor… Read more